Dr Reddy's Laboratories Ltd ADR
RDY: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$92.00 | Nvt | Ynrzltxhg |
Dr. Reddy's Posts Strong Product Launches; Maintaining $60 Fair Value Estimate
No-moat Dr. Reddy’s reported strong product launches in its second quarter that offset the decline of its COVID-19-related product sales. We maintain our fair value estimate of $60 per share.